Top-down proteomic analysis by MALDI-TOF profiling: Concentration-independent biomarkers

Gary L Nelsestuen, Stephen B Harvey, Yan Zhang, Raj S. Kasthuri, Alan R Sinaiko, E. Wesley Ely, Gordon R. Bernard, Monika Homoncik, Bernd Jilma

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Although numerous protein biomarkers have been correlated with advanced disease states, no new clinical assays have been developed. Goals often anticipate disease-specific protein changes that exceed values among healthy individuals, a property common to acute phase reactants. This review considers somewhat different approaches. It focuses on intact protein isoform ratios that present a biomarker without change in the total concentration of the protein. These will seldom be detected by peptide level analysis or by most antibody-based assays. For example, application of an inexpensive method to large sample groups resulted in observation of several polymorphisms, including the first structural polymorphism of apolipoprotein C1. Isoform distribution of this protein was altered and was eventually linked to increased obesity. Numerous other protein isoforms included C- and N-terminal proteolysis, changes of glycoisoform ratios and certain types of sulfhydryl oxidation. While many of these gave excellent statistical correlation with advanced disease, clinical utility was not apparent. More important may be that protein isoform ratios were very stable in each individual. Diagnosis by longitudinal analysis of the same individual might increase sensitivity of protein biomarkers by 20-fold or more. Protein changes that exceed the range of values found among healthy individuals may be uncommon.

Original languageEnglish (US)
Pages (from-to)158-166
Number of pages9
JournalProteomics - Clinical Applications
Volume2
Issue number2
DOIs
StatePublished - Feb 1 2008

Fingerprint

Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Biomarkers
Proteomics
Protein Isoforms
Proteins
Apolipoprotein C-I
Polymorphism
Assays
Acute-Phase Proteins
Proteolysis
Obesity
Observation
Peptides
Antibodies
Oxidation

Keywords

  • Human
  • Mass spectra
  • Plasma

Cite this

Top-down proteomic analysis by MALDI-TOF profiling : Concentration-independent biomarkers. / Nelsestuen, Gary L; Harvey, Stephen B; Zhang, Yan; Kasthuri, Raj S.; Sinaiko, Alan R; Ely, E. Wesley; Bernard, Gordon R.; Homoncik, Monika; Jilma, Bernd.

In: Proteomics - Clinical Applications, Vol. 2, No. 2, 01.02.2008, p. 158-166.

Research output: Contribution to journalReview article

Nelsestuen, GL, Harvey, SB, Zhang, Y, Kasthuri, RS, Sinaiko, AR, Ely, EW, Bernard, GR, Homoncik, M & Jilma, B 2008, 'Top-down proteomic analysis by MALDI-TOF profiling: Concentration-independent biomarkers', Proteomics - Clinical Applications, vol. 2, no. 2, pp. 158-166. https://doi.org/10.1002/prca.200780107
Nelsestuen, Gary L ; Harvey, Stephen B ; Zhang, Yan ; Kasthuri, Raj S. ; Sinaiko, Alan R ; Ely, E. Wesley ; Bernard, Gordon R. ; Homoncik, Monika ; Jilma, Bernd. / Top-down proteomic analysis by MALDI-TOF profiling : Concentration-independent biomarkers. In: Proteomics - Clinical Applications. 2008 ; Vol. 2, No. 2. pp. 158-166.
@article{8d8523abae8e431bbbfe54a25678242b,
title = "Top-down proteomic analysis by MALDI-TOF profiling: Concentration-independent biomarkers",
abstract = "Although numerous protein biomarkers have been correlated with advanced disease states, no new clinical assays have been developed. Goals often anticipate disease-specific protein changes that exceed values among healthy individuals, a property common to acute phase reactants. This review considers somewhat different approaches. It focuses on intact protein isoform ratios that present a biomarker without change in the total concentration of the protein. These will seldom be detected by peptide level analysis or by most antibody-based assays. For example, application of an inexpensive method to large sample groups resulted in observation of several polymorphisms, including the first structural polymorphism of apolipoprotein C1. Isoform distribution of this protein was altered and was eventually linked to increased obesity. Numerous other protein isoforms included C- and N-terminal proteolysis, changes of glycoisoform ratios and certain types of sulfhydryl oxidation. While many of these gave excellent statistical correlation with advanced disease, clinical utility was not apparent. More important may be that protein isoform ratios were very stable in each individual. Diagnosis by longitudinal analysis of the same individual might increase sensitivity of protein biomarkers by 20-fold or more. Protein changes that exceed the range of values found among healthy individuals may be uncommon.",
keywords = "Human, Mass spectra, Plasma",
author = "Nelsestuen, {Gary L} and Harvey, {Stephen B} and Yan Zhang and Kasthuri, {Raj S.} and Sinaiko, {Alan R} and Ely, {E. Wesley} and Bernard, {Gordon R.} and Monika Homoncik and Bernd Jilma",
year = "2008",
month = "2",
day = "1",
doi = "10.1002/prca.200780107",
language = "English (US)",
volume = "2",
pages = "158--166",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
publisher = "Wiley-VCH Verlag",
number = "2",

}

TY - JOUR

T1 - Top-down proteomic analysis by MALDI-TOF profiling

T2 - Concentration-independent biomarkers

AU - Nelsestuen, Gary L

AU - Harvey, Stephen B

AU - Zhang, Yan

AU - Kasthuri, Raj S.

AU - Sinaiko, Alan R

AU - Ely, E. Wesley

AU - Bernard, Gordon R.

AU - Homoncik, Monika

AU - Jilma, Bernd

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Although numerous protein biomarkers have been correlated with advanced disease states, no new clinical assays have been developed. Goals often anticipate disease-specific protein changes that exceed values among healthy individuals, a property common to acute phase reactants. This review considers somewhat different approaches. It focuses on intact protein isoform ratios that present a biomarker without change in the total concentration of the protein. These will seldom be detected by peptide level analysis or by most antibody-based assays. For example, application of an inexpensive method to large sample groups resulted in observation of several polymorphisms, including the first structural polymorphism of apolipoprotein C1. Isoform distribution of this protein was altered and was eventually linked to increased obesity. Numerous other protein isoforms included C- and N-terminal proteolysis, changes of glycoisoform ratios and certain types of sulfhydryl oxidation. While many of these gave excellent statistical correlation with advanced disease, clinical utility was not apparent. More important may be that protein isoform ratios were very stable in each individual. Diagnosis by longitudinal analysis of the same individual might increase sensitivity of protein biomarkers by 20-fold or more. Protein changes that exceed the range of values found among healthy individuals may be uncommon.

AB - Although numerous protein biomarkers have been correlated with advanced disease states, no new clinical assays have been developed. Goals often anticipate disease-specific protein changes that exceed values among healthy individuals, a property common to acute phase reactants. This review considers somewhat different approaches. It focuses on intact protein isoform ratios that present a biomarker without change in the total concentration of the protein. These will seldom be detected by peptide level analysis or by most antibody-based assays. For example, application of an inexpensive method to large sample groups resulted in observation of several polymorphisms, including the first structural polymorphism of apolipoprotein C1. Isoform distribution of this protein was altered and was eventually linked to increased obesity. Numerous other protein isoforms included C- and N-terminal proteolysis, changes of glycoisoform ratios and certain types of sulfhydryl oxidation. While many of these gave excellent statistical correlation with advanced disease, clinical utility was not apparent. More important may be that protein isoform ratios were very stable in each individual. Diagnosis by longitudinal analysis of the same individual might increase sensitivity of protein biomarkers by 20-fold or more. Protein changes that exceed the range of values found among healthy individuals may be uncommon.

KW - Human

KW - Mass spectra

KW - Plasma

UR - http://www.scopus.com/inward/record.url?scp=39649087127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39649087127&partnerID=8YFLogxK

U2 - 10.1002/prca.200780107

DO - 10.1002/prca.200780107

M3 - Review article

C2 - 21136822

AN - SCOPUS:39649087127

VL - 2

SP - 158

EP - 166

JO - Proteomics - Clinical Applications

JF - Proteomics - Clinical Applications

SN - 1862-8346

IS - 2

ER -